A randomized double-blinded phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG N0923 (Alliance) Study
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 7509
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3125
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. R. Molina S. J. Mandrekar G. Dy M. C. Aubry K. A. Ziegler S. R. Dakhil B. A. Sachs J. J. Nieva S. E. Schild K. Burroughs A. Williams C. M. Rudin A. A. Adjei
- Networks:
- Study
- NCCTG-N0923
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: